Granite Shares Advisors LLC Merck & Co., Inc. Transaction History

Granite Shares Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	SELL	$108.61 - $118.38 $22,699 - $24,741	-209 Reduced 2.75%	7,388 $852,000
Q1 2023 Apr 24, 2023	BUY	$102.94 - $114.86 $7,411 - $8,269	72 Added 0.96%	7,597 $808,000
Q4 2022 Jan 26, 2023	SELL	$87.44 - $112.11 $139,729 - $179,151	-1,598 Reduced 17.52%	7,525 $0
Q3 2022 Oct 14, 2022	SELL	$84.53 - $94.96 $84,107 - $94,485	-995 Reduced 9.83%	9,123 $785,000
Q2 2022 Jul 22, 2022	SELL	$83.49 - $94.64 $96,514 - $109,403	-1,156 Reduced 10.25%	10,118 $922,000
Q1 2022 May 06, 2022	SELL	$73.51 - $82.4 $51,236 - $57,432	-697 Reduced 5.82%	11,274 $925,000
Q4 2021 Feb 08, 2022	BUY	$72.28 - $90.54 $865,263 - $1.08 Million	11,971 New	11,971 $917,000

3,820

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Granite Shares Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Granite Shares Advisors LLC with notifications on news.